Trial
NCT04391231
HEMolysis in a Percutaneous Axial Flow LVAD, Effects of Pentoxifylline in a Randomized Controlled Trial
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Cedars-Sinai Medical Center
Collaborators
—
Condition
Hemolysis Intravascular
Intervention
Pentoxifylline Oral Product
Why stopped
Initially the study was underfunded; then, the device we planned to use was changed and the new pump significantly reduced hemolysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-31